Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson’s Disease: A Systematic Review of Observational Studies
出版年份 2015 全文链接
标题
Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson’s Disease: A Systematic Review of Observational Studies
作者
关键词
Levodopa, Bromocriptine, Pramipexole, Cabergoline, Hyperprolactinemia
出版物
CNS DRUGS
Volume 29, Issue 12, Pages 985-998
出版商
Springer Nature
发表日期
2015-11-19
DOI
10.1007/s40263-015-0293-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pergolide Associated Cardiac Valvulopathy Based on Ontario Administrative Data
- (2014) Cindy Zadikoff et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
- (2014) Santiago Perez-Lloret et al. Expert Opinion On Drug Safety
- Risk of Heart Failure Associated with Dopamine Agonists: A Nested Case–Control Study
- (2013) P. H. Hsieh et al. DRUGS & AGING
- Multiple valvular regurgitation associated with bromocriptine therapy
- (2012) Thomas Cautres et al. Archives of Cardiovascular Diseases
- Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinsonʼs Disease and Hyperprolactinaemia
- (2011) Gianluca Trifirò et al. DRUG SAFETY
- The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists
- (2011) Vibeke Guldbrand Rasmussen et al. MOVEMENT DISORDERS
- Dopamine agonist use and the risk of heart failure
- (2011) Christel Renoux et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease
- (2011) M. Mostafa Mokhles et al. PHARMACOLOGICAL RESEARCH
- Regression of Cardiac Valvulopathy Related to Ergot-Derived Dopamine Agonists
- (2010) Renzo Zanettini et al. Cardiovascular Therapeutics
- Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease
- (2010) Santiago Perez-Lloret et al. CNS DRUGS
- Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson’s disease: a systematic review
- (2009) Malcolm Steiger et al. JOURNAL OF NEURAL TRANSMISSION
- B-type natriuretic peptide and cardiovalvulopathy in Parkinson disease with dopamine agonist
- (2009) H. Watanabe et al. NEUROLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- The frequency of cardiac valvular regurgitation in Parkinson's disease
- (2008) Kazuo Yamashiro et al. MOVEMENT DISORDERS
- Bromocriptine use and the risk of valvular heart disease
- (2008) Louis C.S. Tan et al. MOVEMENT DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started